Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 11.3414.7129.3720.808.85

What is the latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS is 11.34 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202411.34
Mar202314.71
Mar202229.37
Mar202120.80
Mar20208.85

How is EV/Core EBITDA of FREDUN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 11.34
-22.91
Mar2023 14.71
-49.91
Mar2022 29.37
41.20
Mar2021 20.8
135.03
Mar2020 8.85 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹345.8 Cr 11.5% 4.5% -7.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,084.0 Cr -0% -4.6% 18.9% Stock Analytics
DIVIS LABORATORIES ₹162,384.0 Cr 8.8% 5.1% 64.4% Stock Analytics
CIPLA ₹118,853.0 Cr 2.4% -1.1% 0.8% Stock Analytics
DR REDDYS LABORATORIES ₹103,143.0 Cr 2.6% -9.9% -0.4% Stock Analytics
ZYDUS LIFESCIENCES ₹101,459.0 Cr 3.6% -0.1% 22.7% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

11.5%

4.5%

-7.3%

SENSEX

0.7%

-0.1%

8.8%


You may also like the below Video Courses